IbisVision target £5m funding

Eye care technology company IbisVision has begun an ambitious £5m funding drive aimed at expanding its global reach, with a focus on the US market.

CEO Mark Roger said: ‘While Glasgow born and bred, we have global ambitions, and you cannot be a global business without a US footprint. Our proposition is very much aligned with the trends the US investment industry is focused on, as evidenced by the continuing support from Adam and Yannick at [venture capital firm] Compiler.

‘With increased funding from US investors, we hope to tap into our international potential with a key focus being the lucrative and expanding US eye-care market.’